Social anxiety—or social phobia—refers to an extreme fear of being observed, judged, or negatively evaluated in interpersonal situations. It is not shyness, although the two are often confused.… Read more.
3 factors with evidence, ordered from most to least effective. Information, not medical advice.
⏱ 3 min read
Social anxiety—or social phobia—refers to an extreme fear of being observed, judged, or negatively evaluated in interpersonal situations. It is not shyness, although the two are often confused. Shyness is a temperamental trait that results in some initial discomfort that later fades. Clinical social anxiety does not fade: the person anticipates rejection, avoids the situations that provoke it, and, when they cannot avoid them, experiences them with intense autonomic activation (sweating, blushing, trembling, tachycardia, a “blank mind”). The toll on life is enormous: relationships that never form, job opportunities that are passed up, progressive isolation, and often the development of secondary depression.
Social anxiety disorder (SAD) is diagnosed when the fear is persistent (more than 6 months), interferes with daily life, is accompanied by avoidance behaviors or a need for “safety” (carrying water bottles for tremor, alcohol before the event, memorized scripts), and causes significant distress. Lifetime prevalence is 7-12%. It usually begins in adolescence, has a chronic course if untreated, and responds well to structured intervention, with response rates of 60-70% when treatment is done correctly.
Neuroimaging studies show hyperactivation of the amygdala and insula during social evaluation tasks, with hypoactivity of the medial prefrontal cortex. The serotonergic system is dysregulated—hence the response to SSRIs—and there is evidence of reduced vagal tone and an exaggerated reactive cortisol response to evaluative social situations (the “socially evaluated cold pressor test” is a classic paradigm). That autonomic hyperreactivity is what the person feels as “everyone is looking at me” even before the conscious cortex formulates the interpretation.
Silexan (oral lavender oil 160 mg/day) has a published trial specifically in social phobia with a significant reduction in LSAS at 10 weeks. It does not replace gradual exposure but may facilitate it by reducing baseline anticipatory anxiety.
L-theanine (200-400 mg/day) has consistent evidence for anticipatory anxiety: it reduces reactive cortisol and subjective anxiety 30-60 minutes before the feared situation (presentation, exam, public speaking), without sedation. It is an ideal intervention for “as-needed use” in mild SAD or as an adjunct in moderate SAD.
As-needed beta-blockers (propranolol 20-40 mg 30-60 min beforehand) are the intervention most used by musicians, speakers, and actors to control tremor and tachycardia in specific performances. They do not address the underlying disorder but they break the vicious circle of “visible tremor → increased anxiety → more tremor.” For occasional use, not chronic use.
SSRIs (paroxetine, sertraline, escitalopram) are first-line pharmacological treatment in moderate to severe SAD, with a 50-60% response at 12 weeks.
CBT specific to social anxiety includes three components: cognitive restructuring (identifying and challenging catastrophic beliefs: “everyone is looking at me,” “I’m going to make a fool of myself”), social skills training (eye contact, starting a conversation, managing silence), and above all graded exposure with a hierarchy. The exposure ladder is built together with the person, starting with the least frightening step (greeting a neighbor, asking someone the time on the street) and gradually climbing to the hardest (giving a presentation at work, going to a party where you know no one). Each rung is repeated until the anxiety drops through habituation. Without this work, no medication cures SAD: it relieves symptoms while it is taken and they return when it is withdrawn.
Acceptance and commitment therapy (ACT) is especially useful when the person has “shrunk” their life by avoiding social situations: it works on the value of human connection as a guiding direction and on commitment to actions aligned with that value, even while carrying the anxiety along. IFS is useful when social anxiety is rooted in early experiences of humiliation, bullying, or family rejection.
Slow breathing (4-7-8 or heart rate coherence) for 5-10 minutes before the social event raises vagal tone and lowers autonomic reactivity. Moderate physical contact (hugs with close people) releases oxytocin and lowers reactivity to social stress for hours. Cutting back on alcohol is key: although it seems to calm you in the moment, it increases social reactivity on the following days. Regular sleep and regular aerobic exercise have a baseline anxiolytic effect comparable to an SSRI at a medium dose.
If social anxiety has led to turning down a promotion, abandoning a career, repeatedly avoiding outings, or if alcohol use before social events appears, it is time to seek help. SAD responds very well to treatment, and the sooner it is addressed, the less entrenched it becomes in the person's life pattern.
⏱ 3 min read
Social anxiety—or social phobia—refers to an extreme fear of being observed, judged, or negatively evaluated in interpersonal situations. It is not shyness, although the two are often confused. Shyness is a temperamental trait that results in some initial discomfort that later fades. Clinical social anxiety does not fade: the person anticipates rejection, avoids the situations that provoke it, and, when they cannot avoid them, experiences them with intense autonomic activation (sweating, blushing, trembling, tachycardia, a “blank mind”). The toll on life is enormous: relationships that never form, job opportunities that are passed up, progressive isolation, and often the development of secondary depression.
Social anxiety disorder (SAD) is diagnosed when the fear is persistent (more than 6 months), interferes with daily life, is accompanied by avoidance behaviors or a need for “safety” (carrying water bottles for tremor, alcohol before the event, memorized scripts), and causes significant distress. Lifetime prevalence is 7-12%. It usually begins in adolescence, has a chronic course if untreated, and responds well to structured intervention, with response rates of 60-70% when treatment is done correctly.
Neuroimaging studies show hyperactivation of the amygdala and insula during social evaluation tasks, with hypoactivity of the medial prefrontal cortex. The serotonergic system is dysregulated—hence the response to SSRIs—and there is evidence of reduced vagal tone and an exaggerated reactive cortisol response to evaluative social situations (the “socially evaluated cold pressor test” is a classic paradigm). That autonomic hyperreactivity is what the person feels as “everyone is looking at me” even before the conscious cortex formulates the interpretation.
Silexan (oral lavender oil 160 mg/day) has a published trial specifically in social phobia with a significant reduction in LSAS at 10 weeks. It does not replace gradual exposure but may facilitate it by reducing baseline anticipatory anxiety.
L-theanine (200-400 mg/day) has consistent evidence for anticipatory anxiety: it reduces reactive cortisol and subjective anxiety 30-60 minutes before the feared situation (presentation, exam, public speaking), without sedation. It is an ideal intervention for “as-needed use” in mild SAD or as an adjunct in moderate SAD.
As-needed beta-blockers (propranolol 20-40 mg 30-60 min beforehand) are the intervention most used by musicians, speakers, and actors to control tremor and tachycardia in specific performances. They do not address the underlying disorder but they break the vicious circle of “visible tremor → increased anxiety → more tremor.” For occasional use, not chronic use.
SSRIs (paroxetine, sertraline, escitalopram) are first-line pharmacological treatment in moderate to severe SAD, with a 50-60% response at 12 weeks.
CBT specific to social anxiety includes three components: cognitive restructuring (identifying and challenging catastrophic beliefs: “everyone is looking at me,” “I’m going to make a fool of myself”), social skills training (eye contact, starting a conversation, managing silence), and above all graded exposure with a hierarchy. The exposure ladder is built together with the person, starting with the least frightening step (greeting a neighbor, asking someone the time on the street) and gradually climbing to the hardest (giving a presentation at work, going to a party where you know no one). Each rung is repeated until the anxiety drops through habituation. Without this work, no medication cures SAD: it relieves symptoms while it is taken and they return when it is withdrawn.
Acceptance and commitment therapy (ACT) is especially useful when the person has “shrunk” their life by avoiding social situations: it works on the value of human connection as a guiding direction and on commitment to actions aligned with that value, even while carrying the anxiety along. IFS is useful when social anxiety is rooted in early experiences of humiliation, bullying, or family rejection.
Slow breathing (4-7-8 or heart rate coherence) for 5-10 minutes before the social event raises vagal tone and lowers autonomic reactivity. Moderate physical contact (hugs with close people) releases oxytocin and lowers reactivity to social stress for hours. Cutting back on alcohol is key: although it seems to calm you in the moment, it increases social reactivity on the following days. Regular sleep and regular aerobic exercise have a baseline anxiolytic effect comparable to an SSRI at a medium dose.
If social anxiety has led to turning down a promotion, abandoning a career, repeatedly avoiding outings, or if alcohol use before social events appears, it is time to seek help. SAD responds very well to treatment, and the sooner it is addressed, the less entrenched it becomes in the person's life pattern.